$3 Million DoD Grant

by | Apr 22, 2024 | PBC

BREAKING NEWS: Plus Therapeutics has been selected for funding by the Department of Defense (DoD) office of the Congressionally Directed Medical Research Programs (CDMRP). The award is expected to commence in Q3 2024 and will support the planned expansion of the...

“Thriving Together”

by | Apr 19, 2024 | LM

Come by our NEW booth at the Living Beyond Breast Cancer Metastatic Breast Cancer Conference this weekend! We have information about Leptomeningeal Metastases and our ongoing ReSPECT-LM Clinical Trial. See you there! 🎗️ ReSPECT-LM Website:...

Head for the Cure: North Texas

by | Apr 18, 2024 | Uncategorized

Join some of the Plus Therapeutics team at the Head for the Cure 5K – North Texas on May 4th! They will be out supporting the local community, cancer research, and “Defeating Brain Cancer Step by Step.” We hope to see you there 🏃🏃‍♂️🏃‍♀️ Event...

Welcome Dr. Brenner!

by | Apr 15, 2024 | Uncategorized

#ICYMI: Plus Therapeutics added Dr. Andrew Brenner to our management team. Dr. Brenner will provide substantial input on the Company’s central nervous system cancer development programs while continuing to maintain his academic practice and laboratory. Full Press...

LBBC Curtain Raiser

by | Apr 11, 2024 | LM

📣 Mark Your Calendars! Plus Therapeutics will be exhibiting at the @livingbeyondbc Thriving Together Metastatic Breast Cancer Conference, April 19-21. Come learn about our ReSPECT-LM clinical trial for Leptomeningeal Metastases and meet some of our team. Event...